The impact of oxaliplatin‐based chemotherapy for colorectal cancer on the autonomous nervous system

The oxaliplatin (ΟΧΑ)‐based regimens FOLFOX and XELOX can cause peripheral neuropathy. It is unknown if ΟΧΑ, alone or in combination regimens, affects the Autonomous Nervous System (ANS). Accordingly, we evaluated the impact of ΟΧΑ‐based chemotherapy on the ANS.

[1]  G. Cavaletti,et al.  Advanced age and liability to oxaliplatin‐induced peripheral neuropathy: post hoc analysis of a prospective study , 2013, European Journal of Neurology.

[2]  N. Shah,et al.  Impact of the U.S. Preventive Services Task Force update for breast cancer screening on mammography utilization in women age 40 to 49. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Guido Cavaletti,et al.  Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. , 2012, Critical reviews in oncology/hematology.

[4]  L. Diaz,et al.  Takotsubo cardiomyopathy and Fluorouracil: case report and review of the literature. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  P. Lozeron,et al.  [Autonomic peripheral neuropathy]. , 2012, Presse medicale.

[6]  T. Fontanges,et al.  5‐Fluorouracil—Induced Tako‐Tsubo—Like Syndrome , 2011, Pharmacotherapy.

[7]  J. Sørensen,et al.  5-Fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity , 2011, Cancer Chemotherapy and Pharmacology.

[8]  J. Dalzell,et al.  The spectrum of 5-fluorouracil cardiotoxicity , 2009, Anti-cancer drugs.

[9]  M. Saif,et al.  Fluoropyrimidine-associated cardiotoxicity: revisited. , 2009, Expert opinion on drug safety.

[10]  A. Argyriou,et al.  A review on oxaliplatin-induced peripheral nerve damage. , 2008, Cancer treatment reviews.

[11]  J. Grem,et al.  Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage‐gated sodium channels , 2005, British journal of pharmacology.

[12]  M. Rocchi,et al.  High activity and reduced neurotoxicity of bi-fractionated oxaliplatin plus 5-fluorouracil/leucovorin for elderly patients with advanced colorectal cancer. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  M. Dimopoulos,et al.  Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  H Kaufmann,et al.  Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy , 1996, Clinical Autonomic Research.

[15]  T. Conroy,et al.  XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  M. Seyfarth,et al.  High Incidence of Angina pectoris in Patients Treated with 5-Fluorouracil , 2003, Oncology.

[17]  J. Cassidy,et al.  Oxaliplatin-related side effects: characteristics and management. , 2002, Seminars in oncology.

[18]  E. Gamelin,et al.  Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures. , 2002, Seminars in oncology.

[19]  A. Anand.  Fluorouracil Cardiotoxicity , 1994, The Annals of pharmacotherapy.

[20]  H. Eyre,et al.  A phase II randomized study comparing sequential and combined intraarterial cisplatin and radiation therapy in primary brain tumors: A southwest oncology group study , 2010, Cancer.

[21]  D. Bild,et al.  Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. , 1992, Hypertension.

[22]  B. Cantwell,et al.  Autonomic neuropathy after cisplatin based chemotherapy. , 1990, BMJ.

[23]  S. W. Hansen.  Autonomic neuropathy after treatment with cisplatin, vinblastine, and bleomycin for germ cell cancer. , 1990, BMJ.

[24]  C. Rosenfeld,et al.  Cisplatin-induced autonomic neuropathy. , 1984, Cancer treatment reports.